Healthcare spending is expected to nearly double to $4.3 trillion by 2017. Who’s most likely to benefit.
CNBC’s Bertha Coombs explains that according to a new study released from economists at the Center for Medicare and Medicaid Services, known as CMS, spending on healthcare will likely double over the next decade.
From a sector standpoint, the study's authors say spending for personal health care services, prescription drug medications, and home health care services will see the biggest growth over the next ten years.
According to sources interviewed by Coombs, Amedisys, Inc (AMED), Humana (HUM) and Stryker Corporation (SYK) appear poised to benefit significantly.
Meanwhile, Pete Najarian suggests watching the following categories and stocks.
“Big Dogger” Pharma
Myriad Genetics (MYGN)
Najarian adds one caveat. These are long term investments, he says, not quick trades. And don’t buy until we know who wins the White House.
Got something to say? Send us an e-mail at firstname.lastname@example.org and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to email@example.com.
Trader disclosure: On Feb.26, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders: Najarian Owns (BIIB), (NOK), (C), (CSCO), (MCD), (MS), (MSFT), (XLF), (XTO) Calls, (YHOO) and (YHOO) Calls; Macke Owns (INTC), (KSS), (MSFT), (ODP), (TSO), (WMT), (DIS), (YHOO); Finerman’s Firm Is Short (IYR), (IJR), (IWM), (MDY), (SPY), Finerman’s Firm Owns (DVA),(AAPL), Finerman’s Firm and Finerman Own (FLS), (HD), Finerman’s Firm Is Short (LEH) and Owns (LEH) Puts; Charles Schwab is a sponsor of Fast Money